ニュース
“SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, ...
Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...
Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.
Panelists discuss the anticipated 2026 updates to the American Academy of Dermatology guidelines for hidradenitis suppurativa ...
Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with ...
Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like ...
Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...
The American Society for Preventive Cardiology (ASPC) marked its 40th anniversary this year at the ASPC Congress on CVD ...
In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses ...
The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.
The humanized IgG4 monoclonal antibody was first approved for myasthenia gravis in the US in 2023, with approvals in Japan ...
A qualitative study found strong support for primary care provider–nephrologist comanagement of chronic kidney disease (CKD), ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する